Systematic review of erythropoiesis-stimulating agent dosing algorithms in hemodialysis patients

被引：0
|
作者：
Meaney, Calvin [1 ]
Gaesser, Jamie [2 ]
Robinson, Ben [2 ]
Krzyzanski, Wojciech [2 ]
Panesar, Mandip [3 ]
Rao, Gauri [4 ]
机构：
[1] SUNY Buffalo, Dept Pharm Practice, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[2] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[3] Erie Cty Med Ctr & Labs, Buffalo, NY USA
[4] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Experiential Educ, Chapel Hill, NC USA
来源：
PHARMACOTHERAPY | 2017年 / 37卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
537
引用
收藏
页码：E235 / E236
页数：2
相关论文
共 50 条
  • [41] Erythropoiesis-stimulating agent hyporesponsiveness was associated with worse survival of hemodialysis patients independent of the serum ferritin level
    Hanafusa, Norio
    Henn, Lisa
    Bieber, Brian
    Hasegawa, Takeshi
    Usui, Tomoko
    Robinson, Bruce
    Karaboyas, Angelo
    Nangaku, Masaomi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2025, 29 (01) : 23 - 33
  • [42] Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study
    Rieko Eriguchi
    Masatomo Taniguchi
    Toshiharu Ninomiya
    Hideki Hirakata
    Satoru Fujimi
    Kazuhiko Tsuruya
    Takanari Kitazono
    Journal of Nephrology, 2015, 28 : 217 - 225
  • [43] Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study
    Fuller, Douglas S.
    Robinson, Bruce M.
    Locatelli, Francesco
    Pisoni, Ronald L.
    NEPHRON, 2018, 140 (01) : 24 - 30
  • [44] Association of Erythropoiesis-Stimulating Agent Dose and Cardiac Magnetic Resonance Imaging Parameters in Patients Undergoing Hemodialysis
    Lefranc Torres, Armida
    Chertow, Glenn M.
    McCausland, Finnian R.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [45] Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
    Goodkin, David A.
    Zhao, Junhui
    Cases, Aleix
    Nangaku, Masaomi
    Karaboyas, Angelo
    AMERICAN JOURNAL OF NEPHROLOGY, 2022, 53 (05) : 333 - 342
  • [46] Dosing and outcomes study of erythropoiesis-stimulating therapies - DOSE
    Fastenau, J
    Memisoglu, A
    Peake, C
    Salva, C
    Howell, J
    McKenzie, SR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 551S - 551S
  • [47] Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study
    Eriguchi, Rieko
    Taniguchi, Masatomo
    Ninomiya, Toshiharu
    Hirakata, Hideki
    Fujimi, Satoru
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    JOURNAL OF NEPHROLOGY, 2015, 28 (02) : 217 - 225
  • [48] ERYTHROPOIESIS-STIMULATING AGENT (ESA) USE AMONG MEDICARE PATIENTS RECEIVING HEMODIALYSIS AND OBSERVATIONS ABOUT PRURITUS
    Bond, T. Christopher
    Graham, Camelia
    Lubeck, Deborah
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : A28 - A28
  • [49] ASSESSMENT OF RECENT ERYTHROPOIESIS-STIMULATING AGENT GUIDELINES CHANGES ON DOSING PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS
    Lafeuille, M. H.
    Bailey, R. A.
    Laliberte, F.
    Senbetta, M.
    Vekeman, F.
    McKenzie, R. S.
    Blacksmith, A.
    Lefebvre, P.
    VALUE IN HEALTH, 2010, 13 (03) : A81 - A81
  • [50] ASSESSMENT OF RECENT ERYTHROPOIESIS-STIMULATING AGENT GUIDELINES CHANGES ON DOSING PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYISIS
    Lafeuille, Marie-Helene
    Mishagina, Natalia
    Bailey, Robert A.
    Senbetta, Mekre
    Lefebvre, Patrick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A56 - A56
12345